ICD-9 code 410.5 for Acute myocardial infarction of other lateral wall is a medical classification as listed by WHO under the range -ISCHEMIC HEART DISEASE (410-414).
ST elevation myocardial infarction (STEMI) of other lateral wall
Includes: cardiac infarction
infarction of heart, myocardium, or ventricle
rupture of heart, myocardium, or ventricle
ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
any condition classifiable to 414.1-414.9 specified as acute or with a stated duration of 8 weeks or less
The following fifth-digit subclassification is for use with category 410:
0 episode of care unspecified
Use when the source document does not contain sufficient information for the assignment of fifth-digit 1 or 2.
1 initial episode of care
Use fifth-digit 1 to designate the first episode of care (regardless of facility site) for a newly diagnosed myocardial infarction. The fifth-digit 1 is assigned regardless of the number of times a patient may be transferred during the initial episode of care.
2 subsequent episode of care
Use fifth-digit 2 to designate an episode of care following the initial episode when the patient is admitted for further observation, evaluation or treatment for a myocardial infarction that has received initial treatment, but is still less than 8 weeks old.
Regional Conferences Are the Latest Buzz Summer is ending, kids are heading back to school, and AAPC is getting excited to host an AAPC Regional Conference in New York City. I hope to meet many of ... [ Read More ]
The National Committee on Vital and Health Statistics (NCVHS) met with several industry experts in preparation for the implementation of the ICD-11 code set in the US market. Committee members and ... [ Read More ]
Several changes to the Merit-based Incentive Payment System (MIPS) track of the Quality Payment System (QPP) are outlined in a proposed rule for 2020 revisions to payment policies under the Physici... [ Read More ]
Changes to payment, coding, and documentation policies for evaluation and management (E/M) services finalized in the 2019 Physician Fee Schedule (PFS) final rule are necessary to align with the Am... [ Read More ]
Expensive cutting-edge cancer therapy is now covered. Last week the Centers for Medicare & Medicaid Services (CMS) finalized their long-awaited decision to make Chimeric Antigen Receptor T-cell... [ Read More ]